放射肿瘤学前瞻性同行评审:多中心机构方案偏差分析
该研究回顾了2017至2022年间一家大型多中心机构全部根治性放疗病例的前瞻性同行评审记录,病例在勾画后、计划设计前被评级为A、B或C。作者认为前瞻性轮廓同行评审可发现计划设计前的偏差。
要点
- B级常见偏差为处方与医嘱不匹配(34.2%)和计划靶区偏差(32.8%)。
- 通科医生B级比例46.9%高于专科医生34.3%(P < .0002)。
核心结论
- 同行评审轮廓查房覆盖100%根治性病例,其中41%在计划设计前需要修改,凸显对所有患者进行前瞻性轮廓同行评审以在计划设计前发现差异的重要性。
- 在放射肿瘤学中实施同行评审可减少放疗计划中的常见偏差,与疾病部位或医生专业经验无关。
研究设计与样本
- 回顾性分析一家大型多中心机构2017至2022年所有根治性放疗病例的前瞻性同行评审记录。
- 病例勾画后、计划设计前接受同行评审并评级为A、B或C,A级无需修改,B级和C级分别需小幅或大幅修改。
- 采用两比例Z检验比较B级评分的比例差异。
主要发现
- B级病例常见错误为处方与医嘱不匹配(34.2%)和计划靶区偏差(32.8%)。
- B级评分例数最多的疾病部位为头颈(20.2%)、前列腺(13.2%)、乳腺(9.1%)和肺(7.9%)。
- 通科医生B级比例46.9% vs 专科医生34.3%(P < .0002)。
- 终身教职与非终身教职医生B级比例40.5% vs 42.2%(P = .0511),无显著差异。
临床怎么用
- 原文结论认为对所有根治性病例实施前瞻性轮廓同行评审有助于在计划设计前发现偏差。
- 原文结论认为实施同行评审可减少放疗计划中的常见偏差,与疾病部位或医生专业经验无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Peer review is essential for radiation therapy (RT) quality assurance and recent studies show that peer review upstream of treatment planning is feasible and can improve RT quality. Herein, we describe protocol deviations detected by our peer review process by the type of deviation, disease site, and physician characteristics. METHODS AND MATERIALS: Once contoured, cases within our department undergo prospective peer review with each case assigned a grade (A, B, or C). "A" cases require no changes, whereas "B" and "C" cases have protocol deviations requiring minor or major modification, respectively, prior to treatment planning. We reviewed all radiation cases with curative intent from 2017 to 2022. We analyzed cases receiving a B score by type of protocol deviation, disease site, and physician characteristics. The 2-proportion Z-test was performed to determine differences in the proportion of B scores. RESULTS: Thirteen thousand ninety-one curative cases underwent peer review across our institution; 58.6% of cases received an "A," 41.3% received a "B," and 0.1% received a "C." Common errors in cases receiving a B score were a mismatch between the prescription and directive (34.2%) or a deviation in the planning target volume (32.8%). The disease sites that accounted for the largest volume of all B scores were head and neck (20.2%), prostate (13.2%), breast (9.1%), and lung (7.9%). Generalists had a greater percentage of B scores compared to specialists (46.9% vs 34.3%, P < .0002). No significant difference in B scores was observed between tenure and nontenure physicians (40.5% vs 42.2%, P = .0511). CONCLUSIONS: Peer-review contour rounds were performed on 100% of curative cases where 41% required modification prior to treatment planning, highlighting the importance of prospective contour peer review for all patients to catch discrepancies upstream of treatment planning. Implementing peer review in radiation oncology can mitigate common deviations in RT planning, irrespective of disease site or physician expertise.
引用
- Shah M, Kapur A, Potters L, et al. Prospective Peer Review in Radiation Oncology: Analysis of Protocol Deviations at a Large Multicenter Institution to Improve Patient Safety. Pract Radiat Oncol. 2025. PMID: 40113038. doi:10.1016/j.prro.2025.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。